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Abstract
Human and animal cryptococcosis due to an unusual molecular type of Cryptococcus gattii (VGII) emerged recently on
Vancouver Island, Canada. Unlike C. neoformans, C. gattii causes disease mainly in immunocompetent hosts, despite
producing a similar suite of virulence determinants. To investigate a potential relationship between the regulation of
expression of a virulence gene composite and virulence, we took advantage of two subtypes of VGII (a and b), one highly
virulent (R265) and one less virulent (R272), that were identified from the Vancouver outbreak. By expression microarray
analysis, 202 genes showed at least a 2-fold difference in expression with 108 being up- and 94 being down-regulated in
strain R265 compared with strain R272. Specifically, expression levels of genes encoding putative virulence factors (e.g.
LAC1, LAC2, CAS3 and MPK1) and genes encoding proteins involved in cell wall assembly, carbohydrate and lipid metabolism
were increased in strain R265, whereas genes involved in the regulation of mitosis and ergosterol biosynthesis were
suppressed. In vitro phenotypic studies and transcription analysis confirmed the microarray results. Gene disruption of LAC1
and MPK1 revealed defects in melanin synthesis and cell wall integrity, respectively, where CAS3 was not essential for
capsule production. Moreover, MPK1 also controls melanin and capsule production and causes a severe attenuation of the
virulence in a murine inhalational model. Overall, this study provides the basis for further genetic studies to characterize the
differences in the virulence composite of strains with minor evolutionary divergences in gene expression in the primary
pathogen C. gattii, that have led to a major invasive fungal infection outbreak.
Citation: Ngamskulrungroj P, Price J, Sorrell T, Perfect JR, Meyer W (2011) Cryptococcus gattii Virulence Composite: Candidate Genes Revealed by Microarray
Analysis of High and Less Virulent Vancouver Island Outbreak Strains. PLoS ONE 6(1): e16076. doi:10.1371/journal.pone.0016076
Editor: Ping Wang, Research Institute for Children and the Louisiana State University Health Sciences Center Pediatrics, United States of America
Received September 10, 2010; Accepted December 7, 2010; Published January 13, 2011
Copyright:  2011 Ngamskulrungroj et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by Endeavour International Postgraduate Research Scholarship (EIPRS) and International Postgraduate Award (IPA) of the
University of Sydney scholarship to PN and a bridging grant of University of Sydney to WM. Also National Institute of Allergy and Infectious Diseases (NIAID) Public
Heath Service AI28388 and AI73896 for JRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: w.meyer@usyd.edu.au
Introduction
The primary pathogen Cryptococcus gattii, previously designated as
Cryptococcus bacillisporus or Cryptococcus neoformans var. gattii, is a
basidiomycetous yeast that in Australia causes disease primarily in
immunocompetent hosts [1]. It is a member of the Cryptococcus
neoformans/C. gattii species complex [2]. Until recently, C. gattii was
considered to be a tropical and subtropical pathogen [3]. However,
the emergence of cryptococcosis due to an uncommon molecular
type of C. gattii (VGII) in humans and animals on Vancouver Island,
BC, Canada, and its more recent spread to mainland British
Columbia and the adjacent Pacific Northwest of the United States
has changed this paradigm [4,5,6,7,8,9]. In addition, C. gattii has
caused human disease in the temperate climates of France, Italy,
Spain, Greece and Colombia [10,11,12,13,14].
The Vancouver Island outbreak emphasized the importance of
understanding the pathobiology of this emerging pathogen [6]. An
early study revealed that a strain (R265) of the predominant
subtype in the outbreak (VGIIa), was more virulent for A/Jcr mice
than an isolate (R272) of the minor subtype (VGIIb), the proposed
parental strain of R265 [15]. Subsequently it was shown in a
sample of 40 VGIIa and VGIIb strains from around the world that
the VGIIa subtype produced more of the virulence determinant,
melanin, than did the VGIIb subtype [16]. The increased
virulence of the VGIIa subtype was confirmed investigating 21
globally-collected C. gattii strains in Balb/c mice [17]. Approxi-
mately one-half of the gene sequences used as MLST markers in
the R265 and R272 strains are identical [15].
Since the beginning of the AIDS era, several cryptococcal
virulence factors have been identified using C. neoformans as a
model [18]. Melanin [19], capsule [20], growth at 37uC [21],
mating type a [22], phospholipase [23], superoxide dismutases
[24], protein kinases [25], urease [26] and cell wall integrity
enzymes [27] have been phenotypically and molecularly charac-
terized as virulence factors that drive invasion of the host and
survival in vivo [18]. Few studies have been performed in C. gattii
and hence the genes regulating its virulence composite have been
inferred from the work in C. neoformans. Recently some evidence for
differences in virulence gene regulation between these two sibling
species has been published [28,29].
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ized inC. gattii, namely phospholipase B [30], superoxide dismutases
[31], protein kinases [28], a transcriptional factor [32] and the
trehalose biosynthetic pathway [29]. The substantial outbreak of
cryptococcosis due to C. gattii in the south-west of Canada and the
north-west of the US has focused attention on the importance of C.
gattii as a primary and emerging pathogen [6]. The study of the
initial C. gattii strains from the Vancouver Island outbreak suggests
that following a natural event involving recombinational exchange
between two ancestral strains, progeny were produced, which were
much more virulent than the parental strains [15]. Taking
advantage of this natural experiment in pathobiology, we utilized
the high and lower virulence strains in an attempt to identify key
components of the C. gattii virulence composite. A recent whole-
genome expression study identified mitochondrial regulation as an
important factor in the enhanced virulence of strain R265 [33].
Another revealed that suppression of the host immune response is
pivotal to the virulence of this yeast [34]. However, neither of these
studies involved characterization of the responsible genes. Thus, we
conducted a comparative transcriptional study between a represen-
tative highly virulent VGIIa strain, R265, and a representative
lower virulent VGIIb strain, R272, which have been used
extensively in previous genetic and virulence studies [6,15,35].
Numerous differences in gene regulation were indentified. Differ-
entially expressed genes potentially responsible for the virulence
composite of C. gattii were further characterized, and their
importance was confirmed by phenotypic analyses of virulence.
Results
Microarray analysis
The microarray analysis was performed under conditions of
carbon and nitrogen starvation and growth at 37uC [36], to mimic
stress conditions as they might be encountered during a human
CSF infection. Extensive transcriptional differences between the
high and low virulent strains, R265 and R272, respectively were
identified (Table S1). All raw data from triplicate experiments
have been submitted to MIAME (http://www.ebi.ac.uk) under the
ArrayExpress accession number: A-MEXP-1133.
Table S2 lists the gene functions of the differentially expressed
genes identified in the microarray experiments via BLASTN
searches against the GenBank database. The genes are grouped
according to their putative biological functions. Open reading
frames with unknown functions were excluded, but can be found
in the Table S1. To follow up a previous reported connection
between C. gattii virulence and mitochondrial gene expression [33],
a blast search against the draft R265 genome was performed.
However, no specific correlation with the mitochondrial genome,
located on the supercontig 25, was found (Table S2).
Among the up-regulated genes, there were several genes which
are related to the three major virulence factors of C. neoformans,
which include: 1) melanin: LAC1 and LAC2 [19,37] and the copper
chaperone, ATX1 [38]; 2) capsule: the capsule-associated gene,
CAS3 [39] and 3) growth at 37uC: the MAP kinase signaling gene,
MPK1 which is critically important for the growth of C. neoformans
at 37uC [21] (Table S2).
MPK1 is also known to regulate cell integrity by controlling the
expression of several genes involved in cell wall assembly [40]. We
noted that genes involved in cell wall assembly in S. cerevisiae [41]
were also differentially expressed in strain R265, including glucan/
chitin biosynthesis and remodeling genes: 1) b-1,6 glucan
synthetase, [42], 2) glucanases [43], 3) chitin synthases, [41], 4)
chitin deacetylase [44] and 5) UDP-N-acetylglucosamine dipho-
sphorylase [43]. In contrast, a chitinase gene (CNI0386), which
plays a role in cell separation during budding [43] was down-
regulated (Table S2).
Many genes involved in cell metabolism, including carbohy-
drate, lipid and ergosterol metabolism, were down-regulated in the
strain R265. Genes involved in cell division and cryptococcal
pheromone receptors (CPRa/STE3) [45] were also down-regulat-
ed, possibly to maintain microbial fitness (Table S2).
Transcriptional analysis of selected up- and down-
regulated genes
Transcription of differentially-expressed genes was confirmed
by real time PCR. Transcription levels of LAC1, CAS3, LAC2,
MPK1 and STE3 and ETF1a genes identified by RT-PCR
correlated with expression levels identified in the microarray
experiments (see footnote to Table S2).
Phenotypic comparisons between the strain R265 and
R272
Since several potential virulence genes namely laccase, a capsule-
associated gene, MAP kinase, cryptococcal pheromone receptor
and ergosterol biosynthesis genes were differentially expressed,
melanin synthesis, capsule production, cell wall integrity/growth at
37uC, fertility and azole sensitivity were compared.
Melanin synthesis
Strain R265 produced more melanin than strain R272.
Specifically, at 30uC, melanin production in strain R265 was
relatively increased on all three melanin-inducing media (Niger seed
agar, dopamine agar and caffeic acid agar) and even more so at
37uC. This was confirmed by quantification of the laccase activity
ontwo substrates,dopamineand epinephrine,(p=0.004)(Figure 1).
Capsule production
When cultured in three different capsule-inducing conditions,
capsule size was larger in strain R265 than in strain R272. The
average capsule to capsule: cell wall to cell wall ratios of strain R265
comparedtostrainR272 were2.1versus1.8inDMEand 3.0versus
2.1 in RPMI with CO2 (Figure 2). All results were statistically
significant (p=0.005 for DME and p,0.001 for RPMI).
Cell wall integrity and growth at 37uC
R265 was more tolerant than R272 to cell wall perturbing agents
calcofluor white and congo red, and slightly more tolerant to CaCl2
and caffeine (Figure 3). On the other hand, although the cell wall
integrity pathway is known to be linked to high temperature
tolerance,thegrowthrateofthe strainR272 at37uC was reduced in
minimal and not highly nutritious media (data not shown).
Fertility
R265 was more fertile than R272, mating with 14 (78%) of the
18 VGII MATa strains tested, while strain R272 mated only with
9 (50%) of the 18 tested strains (p=0.083) (Table 1). The mating
structures were typical of VGII hyphae, basidia and basidiospores
as described in a previous study (Figure 4) [46].
Susceptibility to the antifungal drug, fluconazole
Fluconazole inhibits C14 a-demethylase (ERG11) [47], an
enzyme in the ergosterol biosynthetic pathway. Azole susceptibility
was tested since several genes involved in ergosterol synthesis were
differentially expressed between the strains R265 and R272 (Table
S2). The minimal inhibitory concentration of fluconazole for both
strains was 4 mg/ml.
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in C. gattii
As strain R265 showed higher melanin synthesis, capsule
production and higher cell wall integrity/growth at 37uC, the
highly expressed genes (Table S2) potentially responsible for these
major virulence factors were characterized in the high virulence
strain, R265. The LAC1 (BROAD Institute gene accession
No. CNBG_2144.2), CAS3 (BROAD Institute gene accession
No. CNBG_0047.2) and MPK1 (BROAD Institute gene accession
No. CNBG_2556.2) genes in strain R265 were isolated as
putative 2543-bp, 2121-bp and 1791-bp open reading frames;
these had approximately 82%, 84% and 87% similarities to the C.
neoformans strain JEC21, respectively. Moreover, the coding
sequences of the LAC1, CAS3 and MPK1 genes had approximately
84%, 84% and 92% similarities to the JEC21 genes, respectively
(Figure S1).
Phenotypic analysis of the lac1D mutant in strain R265 revealed
a severe melanin production defect on all melanin-inducing media
(Figure 5A). The complementation of the LAC1 gene to the lac1D
mutant restored melanin production (Figure 5A). However, the
absence of the CAS3 gene did not affect capsule size in any
capsule-induction media (Figure 5B); these results are consistent
with previous reports for both LAC1 and CAS3 in C. neoformans
[19,39]. No other phenotypic defects were found in either lac1D or
cas3D mutants except melanin deficiency in the laclD mutant.
The R265 mpk1D mutant showed a mild growth defect at 37uC,
which was more obvious at 39uC. Compared to the wild type
strain R265 and the R265 mpk1D::MPK1 complemented strain, the
sensitivity to cell wall stresses of the mpk1D mutant was increased in
response to caffeine, calcofluor white and congo red (Figure 6).
Moreover, the mpk1D mutant of strain R265 was defective in
melanin synthesis and capsule production (Figure 7A and 7B). On
the other hand, no defect in filamentation and sporulation was
observed in unilateral crossings with designated strains of the
opposite mating type (results not shown).
To test whether melanin production was controlled by MPK1
via laccases, RT-PCR for transcription of LAC1 and LAC2 was
performed. LAC1 and LAC2 transcription was significantly
decreased in the mpk1D mutant, to 0.07 and 0.33 that of the
wild type strain R265 and the complemented strain, respectively
(p,0.001 and p=0.003). Virulence of the mpk1D mutant was also
Figure 1. Melanin production of strains R265 and R272. Strain
R265 produced more melanin on all melanin inducing media, e.g. A)
bird seed agar at 48 hr at 30uC and B) caffeic acid agar at 48 h at 37uC.
C) Quantitative measurement of the melanin production shows a
higher laccase activity for strain R265 with either dopamine (Dopa) or
epinephrine (Epi) as substrates (standard error bar +/2 2SE).
doi:10.1371/journal.pone.0016076.g001
Figure 2. Capsule formation of strains R265 and R272. Yeast cells were grown in DME at 37uC with 5% CO2 and RPMI-1640 medium at 37uC
with 5% CO2 for 72 h.
doi:10.1371/journal.pone.0016076.g002
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combination of defects in several major virulence factors, the
mpk1D mutants were completely eliminated from the murine lungs
by day 4 of the infection (Figure 8).
Discussion
The present whole genome microarray study revealed extensive
differences in the transcriptional profiles of representative high and
Figure 3. Cell wall integrity tests for strain R265 vs. strain R272 isolates after incubation in YPD medium supplemented with CaCl2,
calcofluor white (CFW), caffeine and Congo red.
doi:10.1371/journal.pone.0016076.g003
Table 1. List of strains used in this study.
Name Country Source Mating type Sub-type Fertility when mating with Reference
R265 R272
R265 Canada Clinical a VGIIa N/A N/A [6]
R272 Canada Clinical a VGIIb N/A N/A [6]
R265lac1D N/A N/A a N/A N/A N/A This study
R265cas3D N/A N/A a N/A N/A N/A This study
R265mpk1D N/A N/A a N/A N/A N/A This study
R265lac1D::LAC1 N/A N/A a N/A N/A N/A This study
R265cas3D::CAS3 N/A N/A a N/A N/A N/A This study
R265mpk1D::MPK1 N/A N/A a N/A N/A N/A This study
LA 47 Brazil Clinical a N/A F F [12]
LA 55 Brazil Clinical a N/A F F [12]
LA 381 Venezuela Clinical a N/A N N [12]
LA 461 Colombia Clinical a N/A N N [12]
LA 499 Colombia Clinical a N/A F N [12]
LA 516 Colombia Clinical a N/A F F [12]
LA 517 Colombia Clinical a N/A F F [12]
LA 524 Colombia Clinical a N/A F N [12]
LA 540 Colombia Clinical a N/A F F [12]
LA 543 Colombia Clinical a N/A N N [12]
LA 547 Colombia Clinical a N/A F N [12]
LA 567 Colombia Clinical a N/A F N [12]
LA 584 Colombia Clinical a N/A F F [12]
LA 599 Colombia Clinical a N/A N N [12]
CBS1930 Aruba Veterinary a N/A F F [73]
WM 05.452 Brazil Clinical a N/A F F [74]
WM 05.415 Brazil Clinical a N/A F F [74]
AV55 Greece Cilnical a N/A F N [13]
N/A= not applicable, N = infertile, F = fertile.
doi:10.1371/journal.pone.0016076.t001
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outbreak, the most important of which were confirmed by
phenotypic analysis. Genes proven to contribute to the virulence
composite of the sibling species, C. neoformans, including melanin,
capsule, cell wall assembly and mating/spore formation were over-
expressed in the highly virulent strain R265. The microarray
results were confirmed by RT-PCR and in vitro virulence
phenotypic studies. Specifically, melanin production, capsule size,
cell wall integrity and fertility were higher in strain R265 than in
the low virulence strain R272. On the other hand, genes involved
in cell cycle and organization of cellular organelles, lipid
metabolism and sterol synthesis were down-regulated in strain
R265. These findings suggest that either these down-regulated
genes are not involved in virulence expression directly or that the
level of suppression is not sufficient to reduce the virulence of
strain R265. Notably, there was no difference in susceptibility to
fluconazole, which inhibits fungal growth primarily by binding to
the ERG11 gene product in the ergosterol biosynthetic pathway,
even though the ergosterol biosynthetic genes were down-
regulated in strain R265. No specific correlation between virulence
and mitochondrial gene expression (R265 supercontig 25) was
found in the current study (Table S2), contradicting a previous
study, which linked mitochondrial gene regulation with high
virulence of the Vancouver Island Outbreak strains when they
Figure 5. Phenotypic study of lac1D and cas3D mutants. A) The lac1D mutant strain exhibited lower melanin production on caffeic acid agar at
30uC as compared with the wild-type R265 strain and its reconstituted strain (lac1D::LAC1). B) No difference in capsule formation was observed in the
cas3D mutant on 5% CO2 DME at 37uC as compared to the wild-type R265 strain and the reconstituted strain (cas3D:: CAS3D).
doi:10.1371/journal.pone.0016076.g005
Figure 4. Mating reactions of the Vancouver Island isolates showing similar mating properties, with typical bacilli shaped
basidiospores being observed for both strains [72]. The dark arrows present basidia and the white arrows identify basidiospores.
doi:10.1371/journal.pone.0016076.g004
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results are most likely due to the fact that both Vancouver Island
Outbreak isolates, R265 and R272, studied in the current
investigation, may share a similar mitochondrial type [33] despite
their different levels of virulence. As such the results obtained in
the current study identify specific expression differences respon-
sible for the differences in the virulence of the two Vancouver
Island Outbreak sub-genotypes, VGIIa and VGIIb.
Three classical virulence factors, melanin, capsule and the
ability to grow at 37uC, have been described for C. neoformans [18].
Many genes have now been linked to these virulence factors.
Though several melanin- and capsule-related genes were up-
regulated in the high virulent strain R265, regulation or functions
of homologous genes may differ between C. neoformans and C. gattii
[28,29]. To confirm that genes encoding virulence determinants in
C. neoformans, share a similar role in the virulence composite in C.
gattii, we created mutants of LAC1, CAS3 and MPK1 in C. gattii
using site-directed mutagenesis. Previously established protocols
were employed [8]. As expected, LAC1 and MPK1 controlled
melanin synthesis and cell wall integrity respectively in C. gattii.
However, although the CAS3 capsular gene was highly up-
regulated in strain R265 compared to strain R272, capsule size
was not reduced in the cas3D mutant. Based on studies in C.
neoformans CAS3 and its gene family are associated with the
construction of the polysaccharide capsule backbone [39], but as
we observed in C. gattii, CAS3 does not influence capsule size [39].
We chose to further characterize the mpk1D mutant since cross talk
between the protein kinase C (PKC) signaling pathway and other
virulence pathways, especially those involving melanin has been
demonstrated in C. neoformans [27]. In fact, we found that MPK1
Figure 6. Growth of the wild type R265 stain, mpklD mutant and reconstituted mpk1D::MPK1 strain under different temperatures
and cell wall stress conditions. Cells were grown on YPD at different temperatures or in the presence of cell wall disturbing agents as indicated.
doi:10.1371/journal.pone.0016076.g006
Figure 7. A) Phenotypic impact of mpklD on capsule, melanin, and control of laccase gene transcription. Capsule production test in DME
with 5%CO2 at 37uC, B) Melanin synthesis test on Caffeic acid agar at 37uC, C) MPK1, LAC1 and LAC2 transcription level of the mpk1D mutant (white
bars) were 0, 0.07 and 0.33 times to the wild type R265 strain, respectively. No significant differences between the transcriptions between the wild
type and the mpk1D::MPK1 strain.
doi:10.1371/journal.pone.0016076.g007
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Further transcription analysis revealed that MPK1 regulated
melanin production through the LAC1 gene. On the other hand,
the essential capsule-producing genes, CAP10, CAP59, CAP60 and
CAP64, were not differentially regulated in the mpk1D mutant (data
not shown). Finally, as a result of the combined defects in the
major virulence phenotypes, this mutant exhibited a severe
virulence defect measured as survival in our murine inhalational
model of C. gattii infection.
Whether basidiospores are responsible for human cryptococco-
sis is still uncertain. However, it has been proposed that
basidiospores are the source of infection, as their size are small
enough to reach the lung alveoli [48]. Thus, the relative efficiency
and density of spore production by either sexual reproduction or
haploid fruiting may affect the environmental concentration of
infectious particles and hence pathogenicity. A previous study
revealed that the Vancouver Island outbreak strains had an
unusually high fertility and high concentrations of airborne
propagules [6,8]. When tested for their fertility, strain R265 was
more fertile than strain R272 suggesting that the genes controlling
mating/sporulation might be more easily induced. Consistent with
this hypothesis, the CHS5 and CHS7 genes involved in mating
were induced in strain R265 but the a-factor pheromone receptor
STE3a was suppressed. In accordance with the fact that a C.
neoformans CPRa (STE3a) mutant exhibited a defect in sexual
filamentation but not haploid fruiting [45], our expression data
may favor the occurrence of asexual sporulation in strain R265.
On the other hand, glyoxal oxidase genes which are required to
determine the mating fertility were in addition to the CHS5 and
CHS7 genes also up-regulated in strain R265, supporting the
higher fertility seen in strain R265. Similar findings were observed
in Ustilago maydis were the glyoxal oxidase 1, GLO1, was also
required for filamentous growth and virulence [49].
Genes controlling the cryptococcal cell cycle and organization
of cellular organelles may also affect virulence as seen in several
fungal pathogen including U. maydis [50], C. neoformans [51] and S.
cerevisiae [52]. Thus, the mitotic regulatory genes seem to be
important for the fitness of the yeast. Unexpectedly, we found that
these genes were suppressed in the more virulent strain R265 of C.
gattii. However, in U. maydis, expression of Clb2 cyclin varies with
the stage of infection and is suppressed at distinct stages in the
process [53]. A similar scenario might take place in C. gattii, which
could explain the reduction in the transcription of cell cycle-
associated genes in strain R265.
In C. neoformans, lipids provide energy and act as regulator(s) of
pathobiological processes [54]. Our microarray analysis showed
that transcription levels of genes involved in fatty acid b-oxidation
differ between the two C. gattii strains. Fatty acid b-oxidation has
been correlated with the virulence of U. maydis [55]. The MFE2
gene, which encodes a multifunctional enzyme that catalyzes the
second and third reactions in b-oxidation of fatty acids in
peroxisomes, was necessary for full virulence although it was not
required for the production of filaments during mating in vitro.I n
C. neoformans, the fatty acid synthase genes (FAS1 and FAS2) are
essential [56], but the peroxisomes which contain the enzymes of
b-oxidation are not [57]. Although it is uncertain whether this
pathway is part of the virulence of C. gattii, our expression analysis
suggests that it is at least differentially regulated.
Sterols are essential structural and regulatory components of the
eukaryotic cell membrane [58]. Ergosterol, an end-product of this
biosynthetic pathway, is the main sterol in yeasts. Like cholesterol
in mammalian cells, ergosterol affects membrane fluidity and
permeability [59]. Although a direct relationship between the
ergosterol biosynthetic pathway and cryptococcal virulence has
not yet been reported, genes involved in ergosterol synthesis were
suppressed in the high virulent strain R265. However, a
correlation between virulence and the ergosterol synthesis pathway
has been suggested previously [60]. It was reported that a pre-
treatment with subinhibitory concentrations of azoles in vitro
reduced cryptococcal virulence in vivo [61]. However, no difference
in the susceptibility to the azole, fluconazole, which targets ERG11
in the fungal cell, was found. This implies that only a reduction in
expression of genes in the pathway does not always affected azole
resistance of the yeast. Moreover, the reduced activity of the
ergosterol biosynthesis under the herein used condition, mainly the
growth at 37uC, likely reflects the reduction of the need for sterols
in membrane fluidity at high temperatures [62], which may
explain the limited effectiveness of those drugs in febrile patients.
The herein presented results suggest that the comparison of the
transcriptional profiles of different strains can be used to identify
virulence genes or link specific genes with virulence. They support
the concept that gene dosage or elevated transcripts can be linked
to yeast phenotype for certain genetic loci, including virulence
determinants.
Limitations of the approach we have taken for transcriptional
profiling in this study include the following: The microarray
available to us at the time of starting the work was based on a
serotype D strain, which resulted in the fact that only 51% of the
70 mers probes of this array had $90% identity to the sequences
of the strain R265 (Jason Stiajich, personal communication). This
may mean that some of the differentially expressed genes were not
detected. Only 50–60% of the genes on the microarray passed on
our initial filtering (data not shown). However, based on the high
sequence similarity between the coding regions of C. neoformans var.
neoformans and C. gattii (see also the result section, Figure S1 and
[28,29,31]) and the successful previous use of this mircroarray to
study gene expression differences in the closely related variety C.
neoformans var. grubii [63], it is a valuable tool to examine expression
differences between the two VGII outbreak strains, compared in
the current study. In addition to the array-based limitations, there
may have been some mismatches in the hybridization results since
the strains R265 and R272 are not genetically identical. However,
according to MLST data based on 30 genetic loci and the mating
type locus, there is less than 1% genetic difference between both
strains [15]. Thus, the possibility of a mismatch between these
strains is very low and should not have had a significant effect on
Figure 8. The organ burden of the wild type R265 strain, the
mpk1D mutant and the complemented strain in Balb/c mice
lungs. The mpk1 mutant was not detected in any of the lungs (*).
doi:10.1371/journal.pone.0016076.g008
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differentially genes was obtained using a single environmental
condition and time point. Additional genetic determinants of
virulence may be identified using different growth conditions.
In conclusion, substantial differences between the newly
emerged and highly virulent VGIIa subtype (represented by strain
R265) and the less virulent VGIIb subtype (represented by strain
R272) of C. gattii have been identified by transcription profiling.
Despite the genetic similarities between R265 and R272 [15], key
differences in virulence (e.g. LAC1, LAC2, CAS3 and MPK1),
housekeeping (cell wall assembly, carbohydrate and lipid metab-
olism) and mitotic regulatory genes were identified. Further
characterization of three putative virulence genes, LAC1 (melanin
synthesis), CAS3 (capsule production) and MPK1 (MAP kinase)
revealed that over-expression of LAC1 and MPK1 was associated
with an enhanced virulence phenotype in vitro and in vivo, whereas
CAS3 did not influence capsule size in vitro, but was associated with
enhanced virulence in vivo (data not shown). A C. gattii serotype B
microarray has now become available [33] and will allow gene
expression in C. gattii strains to be studied directly. Nevertheless,
the present study has highlighted strain-dependent differences in
gene expression that correlate with high and lower virulence in a
significant newly emerged pathogen. This work provides a basis
for further investigations of mechanisms that regulate the virulence
composite within pathogenic fungi.
Materials and Methods
Strains and Growth Conditions
The strain R265, representing the high virulent VGIIa
genotype and strain R272 representing the low virulent VGIIb
genotype causing the Vancouver Island cryptococcosis outbreak,
identified in a previous study [15], were chosen for microarray
comparison. The strains were retrieved from the freeze-dried
culture collection of Molecular Mycology Research Laboratory,
Westmead Hospital (Table 1). Each strain was maintained on
Yeast Peptone Dextrose (YPD) agar (2% glucose, 2% peptone, 1%
yeast extract, 2% agar) at 30uC and then subjected to the studies
described below. In experiments using a specific number of colony
forming units (CFU)/ml or optical density at 600 nm as starting
points, C. gattii strains were initially grown overnight in YPD broth
at 30uC and counted by hemocytometer for subsequent studies.
DNA isolation
Genomic DNA was extracted and purified according to the
method described previously with modification [64]. Briefly,
100 ml of the yeast pellet was frozen in a 1.5 ml microcentrifuge
tube for 30 minutes at 220uC. 500 ml of lysis buffer (0.5% SDS,
1.4% NaCl, 0.73% EDTA, 0.2 M Tris-HCl) and 5 mlo f2 -
mercaptoethanol was added and incubated at 65uC for 1 hour.
The mixture was vortexed vigorously. The DNA was purified by
25:24:1 phenol:chloroform:isoamyl alcohol and precipitated with
isopropanol. The DNA pellet was washed once by 70% ethanol
and resuspended in 100 ml of sterile double-distilled deionized
water.
mRNA isolation
In order to obtain mRNA from nutritionally stressed isolates,
strains R265 and R272 were initially grown in YPD broth at 30uC
for 24 h to saturation (,10
8 CFU/ml) and then pelleted. Cells
were resuspended in equal volume of minimal medium (0.1%
glucose YNB without amino acid and ammonium sulfate from
Gibco, CA, USA) and incubated at 37uC for 1 h as previously
published [36]. Cells were pelleted by centrifugation for RNA
extraction. The yeast cell pellet was lyophilized and RNA was
extracted using 0.5 mm glass beads vortexed in TrizolH reagent
(Invitrogen, CA, USA) according to the manufacturer’s instruc-
tions. The extracted RNA was further purified with the QiagenH
RNA mini kit (Qiagen, CA, USA) according to the manufacturer
protocol.
cDNA synthesis and labeling
In order to detect gene expressions by both R265 and R272
strains, a reference cDNA pool was prepared by mixing together
an equal amount of RNA obtained from both strains after growth
for 1 hr in eight different growth conditions based on previous
publication [36]. The eight different growth conditions were as
follows: I: YPD medium, 30uC; II: YPD medium, 37uC; III: YPD
medium, 39uC; IV: complete YNB medium with 0.1% glucose
[glucose limiting], 37uC; V: YNB without amino acid and
ammonium sulfate with 0.1% glucose [nitrogen limiting], 37uC;
VI: RPMI medium with 54 mM MOPS pH 7.3 incubated in
room air, 37uC; VII: RPMI medium with 29 mM NaHCO3 and
25 mM MOPS pH 7.3 incubated in 5% CO2,3 7 uC; and VIII:
RPMI medium with 54 mM MOPS and 0.75 M NaCl, 37uC.
Fluorescent cDNAs were synthesized during reverse transcription
of 10 mg of the total RNA reference pool by incorporating Cy3 dye
(Amersham, NJ, USA) coupled to the amino-allyl group at the
Duke Microarray Facility according to established protocols for
custom spotted arrays (http://microarray.genome.duke.edu/).
The cDNA from each strain was individually labeled with Cy5
dye as described above and competitively hybridized against the
reference pool.
Microarray hybridization
A whole-genome 70-mer oligonucleotide DNA microarray
corresponding to each predicted open reading frame of the C.
neoformans serotype D genome (strain JEC21) with additional genes
of the MATa and MATa loci from all serotypes was used. The
composition of the microarray is deposited at MIAME (http://
www.ebi.ac.uk) with the physicalArrayDesign name: DukeCND
and the ArrayExpress accession: A-MEXP-1133. The microarray
was designed and created by the Heitman Laboratory and the
Duke Microarray Facility as described previously [63]. All
hybridizations and data acquisitions were performed at the Duke
Microarray Facility (http://microarray.genome.duke.edu/) ac-
cording to their established protocols.
Microarray data analysis
Microarray hybridizations were performed in triplicates for
each strain. The comparison of the gene expression between the
two strains was performed as follows: Microarray data were
imported into the GeneSpring GX version 7.3.1 software (Agilent
Technologies, CA, USA) and initial background subtractions were
performed based on negative controls and intensity-dependent
(Lowess) normalization using the replicate cross-gene error model
implemented in the software. The background-subtracted data
were then filtered based on confidence using the Benjamini
Hochberg false-discovery rate and on the fold change using the
cut-off point of a 2-fold difference implemented Table in the
GeneSpring software package. Finally, the data were statistically
analyzed by one-way ANOVA using parametric tests (not
assuming variances equals) and p values of #0.05 to obtain the
list of differentially expressed genes for further evaluation (Table
S1). All genes with annotated function were blasted against the
Saccharomyces cerevisiae genome database (http://www.yeastgenome.
org/) and the non-redundant GenBank database to name each
gene according to its homolog. Unknown or hypothetical genes
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GenBank. When this search resulted in significant homologies (E
value,e
250), the closest gene homologues were assigned to those
sequences. The protein sequences of the corresponding JEC21
genes were blasted against the draft R265 genome (Cryptococcus
gattii serotype B Sequencing Project, Center for Genome
Research, http://www.broadinstitute.org/annotation/genome/
cryptococcus_neoformans_b/MultiHome.html) to obtained their
supercontig positions (Table S2).
Transcriptional analysis
To verify the obtained microarray results three genes (LAC1,
CAS3 and MPK1) from the up-regulated gene group, one gene
(STE3) from the down-regulated group and one gene (ETF1a) with
no expression differences were chosen to perform real time (RT-)
PCR. The RT-PCR was performed as described previously [36]
comparing to a house keeping gene, ACT1, using the -RTF and -
RTR primers (Table 2). Induction levels (n-fold) were calculated
by Microsoft Excel 2003 and compared directly between the two
strains.
Melanin synthesis test
Niger seed agar, caffeic acid agar and dopamine agar (0.5 mM
dopamine) were used to test for melanin production [65]. Both
strains were diluted and grown on those media at 30uC and 37uC.
The ability to produce melanin was compared at 24 and 48 h by
examining for the appearance of brown yeast colonies. Quanti-
fication of melanin production (laccase activity) was performed in
triplicate according to a modified method described previously
[37], using 0.1% glucose YNB without amino acid and
ammonium chloride (Becton, Dickinson and CompanyH, MD,
USA) with either 10 mM dopamine HCl (Sigma-AldrichH, MD,
USA) or 0.5 mM epinephrine (Sigma-AldrichH, MD, USA).
Capsule production
Capsule-inducing conditions were used. Briefly, each strain of C.
gattii was grown overnight in YPD broth at 30uC. Yeast cells were
then washed and grown to a cell density of 10
6–10
7 cells/ml using
the following conditions: Dulbecco’s modified Eagle’s medium
(DME) or RPMI with MOPS, HCO3, pH 7.3, in 5% CO2 at
37uC [66,67]. Capsule size was quantified by light microscopy for
at least 100 cells that had been cultured for 72 h and suspended in
India ink using encapsulated to naked yeast size (cell wall to cell
wall diameter) ratios.
Cell wall integrity test
Dilutions of each strain were grown on YPD containing 0.2 M
CaCl2, 7 mg/ml Calcofluor white, 5 mg/ml Congo red or 1 mg/
ml Caffeine, which are known to cause perturbations of yeast cell
wall [27,68].
Growth at 37uC test
Both strains were diluted and grown on either YPD or minimal
media with 2% agar at 37uC.
Mating test
Mating assays were carried out on V8 medium [69] (5% [vol/
vol] V8 juice, 2 mM KH2PO4, 4% [wt/vol] agar). The ability to
mate was tested against the VGII mating type a strains listed in
Table 1. The molecular type and mating type of each strain were
confirmed by URA5 gene RFLP analysis [12] and mating type
specific PCR [8]. Strains cultured on YPD agar for 2 days, were
patched onto solid mating medium either alone or mixed with the
mating type a strains. Plates were incubated at room temperature
in the dark for 3 weeks and examined by light microscopy for
filamentation and basidiospore formation. All experiments were
done in duplicate using V8 media at pH 5 and 7.
Fluconazole susceptibility
Antifungal susceptibility was determined using the CLSI broth
microdilution method (M27-A2) [70].
Characterization of LAC1, CAS3 and MPK1 genes
All genes were first identified in BLASTN searches against the
Cryptococcus gattii strain R265 genome database (Cryptococcus gattii
serotype B Sequencing Project, Center for Genome Research,
http://www.broad.mit.edu) using homologous genes from the
Cryptococcus neoformans strain JEC21. Deletion mutants and
reconstituted strains were then created from strain R265 according
to an established protocol [71]. Knockout constructs were created
as previously described [8]. Briefly, the 59 (primers -F1 and -R2)
and 39 (primers -F2 and -R1) flanking regions of the genes of
interest were linked to the nourseothricin resistance cassette
(primers NatF and NatR) by using overlapping PCR (Table 2).
The resulting knockout constructs were biolistically transformed
into strain R265 on YPD-sorbitol plates and then incubated at
30uC for 16 to 20 hr. Cells were resuspended in YPD broth,
re-plated onto medium containing nourseothricin and further
incubated for 3 to 4 days at 30uC. Mutants were selected based
on nourseothricin resistance and confirmed by both PCR
(primers -EF and -ER) and Southern hybridization methods.
The mutants were reconstituted by transforming a reconstituted
construct for each gene. The constructs were generated using
overlapping PCR by linking each gene, amplified with primers
-RCF and –RCR, with the neomycin resistance cassette (primers
NatF and NatR) (Table 2). The reconstituted strains were then
selected based on the G418 resistance and confirmed by
conventional PCR using primers -FI and –RI, to check for
construct insertion, and real time PCR with gene-specific primers,
to test for recovery of wild-type transcription levels. (Primer
sequences are listed in Table 2).
Murine inhalation model
Balb/c mice were inoculated intranasally with 10
5 cells in 50 mL
PBS, divided and pipetted into each nostril [15]. Mice were
housed and supplied with food and water ad libitum. Groups of 15
mice were infected using the wild-type strain R265, mpk1D mutant
and mpk1D::MPK1 complemented strain (approved by the Western
Sydney Area Health Service Animal Ethics Committee, Protocol
Number 5020.04). Quantitative cultures of lung and brain were
used to compare tissue burdens between groups of mice sacrificed
on day 4, 7 and 14 following inoculation. Lung and brain were
homogenized, diluted and plated out onto YPD agar to determine
the number of CFU/g of tissue, which was plotted against the time
to determine the progression of the infection.
Ethics Statement
Project Title: "Pathogenic fungi - Linkage between genotype
and clinical disease? C. neoformans/C. gattii spp. complex as a model
system. Approved by the Westmead Hospital Animal Ethics
Committee, Protocol Number 5020.04.
Statistical analyses
All statistical analyses including t-test and Chi-square test were
conducted in SPSS version 15.0 (LEAD Technologies, USA). Data
were statistically significant when p value,0.05.
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Primers Primers sequences Note
RLAC1RTF 59 ACCTTCATGGCAACGAGTTC 39 RNA quantification of LAC1
RLAC1RTR 59 ACAACCACAGCCAACTTTCC 39 RNA quantification of LAC1
RCAS3RTF2 59 CTGACGCCTGTTGAGAACAATG 39 RNA quantification of CAS3
RCAS3RTR2 59 GTCAGCGTATGCTCTCCAGGTT 39 RNA quantification of CAS3
RLAC2RTF 59 ACCCTTTACTTCGTGTCGTCCA 39 RNA quantification of LAC2
RLAC2RTR 59 TCCACCCTCCATCCAGAAAGTA 39 RNA quantification of LAC2
RMPK1RTF 59 TGGATTTGTTGAGCAAGCTG 39 RNA quantification of MPK1
RMPK1RTR 59 TCCTTACAGGAGGCATGGAG 39 RNA quantification of MPK1
RSTE3RTF 59 TGGCTAGCGCCTCTCTTATC 39 RNA quantification of STE3
RSTE3RTR 59 CCGAAATAACTGCCTTCCAA 39 RNA quantification of STE3
RETF1RTF 59 GCTGCTAGGGTCGTATCTGG 39 RNA quantification of ETF1
RETF1RTR 59 ACATACAGCTCAGGGGCAAC 39 RNA quantification of ETF1
RACT1RTF 59 GTCCTACGAGCTTCCTGACG 39 RNA quantification of ACT1
RACT1RTR 59 GCAGACTCGAGACCAAGGAG 39 RNA quantification of ACT1
NatF* 59 CATGCAGGATTCGAGTGGCATG 39 NAT
r and NEO
r cassette
NatR* 59 GGAGCCATGAAGATCCTGAGGA 39 NAT
r and NEO
r cassette
RLAC1F1 59 CGACAGTCCTTGCTTCATCA 39 LAC1 construct amplification (mutation)
RLAC1F2 59 TCCTCAGGATCTTCATGGCTCC GCTCGGCTGAAGATTCTTTG 39 LAC1 construct amplification (mutation)
RLAC1R1 59 CTCACCTACGGGGAAGTTCA 39 LAC1 construct amplification (mutation)
RLAC1R2 59 CATGCCACTCGAATCCTGCATG TTGACTATCCCCCGCATTAC 39 LAC1 construct amplification (mutation)
RCAS3F1 59 AACTGGAAATGGTGGTGAGC 39 CAS3 construct amplification (mutation)
RCAS3F2 59 TCCTCAGGATCTTCATGGCTCCC ATCTGGGTAATTGGGATGG 39 CAS3 construct amplification (mutation)
RCAS3R1 59 TTTGGGCGATCGGTATAGAG 39 CAS3 construct amplification (mutation)
RCAS3R2 59 CATGCCACTCGAATCCTGCATG CATGTAAAAATGGCGGAATG 39 CAS3 construct amplification (mutation)
RLAC1EF 59 TGCCTTATGGGATTTTCAGG 39 LAC1 construct insertion confirmation
RLAC1ER 59 GAGATTCCCGCTGATATTGC 39 LAC1 construct insertion confirmation
RCAS3EF 59 CGGTACGCACTCCTTGAACT 39 CAS3 construct insertion confirmation
RCAS3ER 59 GTGGAAGAGTGGACGTGGAT 39 CAS3 construct insertion confirmation
RLAC1FI 59 CATCAACGGTCGTGTAGGTG 39 LAC1 insertion confirmation
RLAC1RI 59 TGTACCATCGGTCTCCACAA 39 LAC1 insertion confirmation
RCAS3FI 59 GCGGCCTATATGGATTCTCA 39 CAS3 insertion confirmation
RCAS3RI 59 CGCATACTCACCAACCATTG 39 CAS3 insertion confirmation
RLAC1RCF 59 TGTTCCCATCATCTTTCCTTGG 39 LAC1 construct amplification (complementation)
RLAC1RCR 59 CATGCCACTCGAATCCTGCATG GATTTCGTTCGCTTGGTGTTTC 39 LAC1 construct amplification (complementation)
RCAS3RCF 59 GGGGCGTAAGGAATGCTAAAAC 39 CAS3 construct amplification (complementation)
RCAS3RCR 59 CATGCCACTCGAATCCTGCATG CGGTGGCTTTCCTGTTCTTATG 39 CAS3 construct amplification (complementation)
RMPK1F1 59 CGGGGCACTATATGTCGAGT 39 MPK1 construct amplification (mutation)
RMPK1F2 59 TCCTCAGGATCTTCATGGCTCC TCGAGTCTGTAACTGTTGTCGAA 39 MPK1 construct amplification (mutation)
RMPK1R1 59 CATCATCCGGCTAGTGGTC 39 MPK1 construct amplification (mutation)
RMPK1R2 59 CATGCCACTCGAATCCTGCATG GGGGTGTTGTCCATGGTATG 39 MPK1 construct amplification (mutation)
RMPK1EF 59 CAGCCATCACCTCATCCTTT 39 MPK1 construct insertion confirmation
RMPK1ER 59 GGCTTTTGGTCGTCTACTGC 39 MPK1 construct insertion confirmation
RMPK1FI 59 CCCCTCGCGATACTAATTCA 39 MPK1 insertion confirmation
RMPK1RI 59 TATGCGTGCGATCAGCTTAC 39 MPK1 insertion confirmation
RMPK1RCF 59 GATCGGGGCACTATATGTCGAG 39 MPK1 construct amplification (complementation)
RMPK1RCR 59 CATGCCACTCGAATCCTGCATG GGGTTGGATGAGGAAATGTTGA 39 MPK1 construct amplification (complementation)
*[56].
doi:10.1371/journal.pone.0016076.t002
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Figure S1 Alignment of the coding regions of LAC1 (A), CAS3
(B) and MPK1 (C) gene sequences of the C. neoformans var.
neoformans, VNIV, strain JEC21 and the C. gattii, VGIIa, strain
R265, revealing 84%, 84% and 92% similarities to the JEC21
genes, respectively.
(TIF)
Table S1 Complete list of all up- and down-regulated genes
including open reading frames with known and unknown
functions.
(DOC)
Table S2 List of gene functions of differentially expressed genes
with transcription levels, which are at least 2-fold higher or lower
in strain R265 vs. strain R272.
(DOC)
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